Hi,
I needed your views on a caes study of Sun Pharma.
It is a Nifty50 stock. However below are the points
PROS
- It is Nifty 50 which is +ve
- It has reduced debt which is +ve
CONS
- It has low return on equity of 9.77% for last 3 years.
- The company has delivered a poor growth of 3.69% over...